The present invention relates to antibodies that bind human programmed cell death 1 (PD-1), and may be useful for treating cancer alone and in combination with chemotherapy and other cancer therapeutics.本發明係關於結合人類程式性細胞死亡1(PD-1)且可單獨及與化學療法及其他癌症治療法組合用於治療癌症之抗體。